HIV

The AJMC^® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com

Poor Well-Being in HIV Associated With SDOH Adversities

By Julia Bonavitacola

April 16th 2025

Women living with HIV in Canada were found to have worse wellbeing when they had adversities related to social determinants of health (SDOH).

Money | Image credit: Stillfx - stock.adobe.com

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

By Julia Bonavitacola

April 3rd 2025

HIV Prevention | Image credit: Nadzeya - stock.adobe.com

Elimination of Division of HIV Prevention Could Have Consequences for HIV Response

By Julia Bonavitacola

March 25th 2025

PrEP | Image credit: wladimir1804 - stock.adobe.com

Elimination of HIV Prevention Division Being Considered by Trump Administration

By Julia Bonavitacola

March 20th 2025

Different forms of ART | Image credit: jarun011 - stock.adobe.com

Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP

By Julia Bonavitacola

March 12th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.

Continuing Medical Education

April 19th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

December 1st 2014

On World AIDS Day, Advocates Mark "Tipping Point" Amid Complaints About Drug Prices in US

Mary K. Caffrey

On World AIDS Day, advocates mark "the beginning of the end" of the pandemic. In the United States, 2014 has been marked by battles between patient advocacy groups and some payers over the price of generic HIV drugs on exchanges under the Affordable Care Act.

October 31st 2014

Medicare Budget Pinched By Payments for the Departed

An investigation into 2012 Medicare claims for HIV-infected patients unearthed payment for prescriptions that were filled up to 32 days after the patient's passing.

October 21st 2014

For Those With HIV and HCV, New Therapies Offer Hope, but Managing Costs Brings Consequences

October 21st 2014

ACA to Increase Shift of HIV Screening to Primary Care Settings

September 6th 2014

Researchers Receive $23.8 Million Grant to Test an Innovative Model to Improve HIV Prevention and Care

Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs.

August 22nd 2014

Triple-Combo Single Pill for HIV Approved

Triumeq(R), the first-ever single pill triple drug combination against HIV, was approved absed on the results of 2 clinical trials.

August 8th 2014

Providers Face Challenges with Managing Elderly HIV/AIDS Patients

Katie Sullivan, MA

Older patients who are diagnosed with HIV/AIDS present a variety of challenges for providers, especially when it comes to controlling their costs of care.

July 28th 2014

Study Reports Exclusion from Trials Responsible for Poor Outcomes in HIV-Positive Cancer Patients

HIV-positive individuals are not usually enrolled in clinical trials, resulting in a knowledge-gap on their treatment options.

July 24th 2014

CDC Lab Safety Point Person, Dr. Michael Bell, to Give Keynote on Hospital Safety at AJMCLive Event

Dr. Michael Bell, previously announced as the keynote speaker for the September 25-26 live meeting hosted by The American Journal of Managed Care, this weekend discussed his role in overhauling lab safety at the Centers for Disease Control and Prevention in Atlanta. Attendees at AJMCLive's Atlanta conference, "Value-Based Decision-Making in Infectious Disease," will have the chance to hear Dr. Bell discuss the prevention of hospital-acquired infections.

July 23rd 2014

Entecavir Falls Short of Protecting Hep B-infected Patients from HCC

However, a point to note is that this was a small cohort study without a comparator arm.

July 8th 2014

Patient Advocates Voice Concern Over Drug Benefit Plan Design

Katie Sullivan, MA

The Affordable Care Act (ACA) prohibits insurance companies from rejecting new customers based on their pre-existing health conditions. Yet, a recent report alleged that 4 Florida-based payers may have structured their prescription drug benefit plans in a way which does just that.

June 30th 2014

CDC's Michael Bell to Give Keynote at AJMC Infectious Disease Conference in Atlanta

The American Journal of Managed Care will host a two-day event September 25-26, 2014, in Atlanta taking on some of healthcare's biggest challenges in infectious disease, including HIV, MERS and how to pay for new therapies for hepatitis C. Giving the keynote address will be Michael Bell, MD, deputy director of the Centers for Disease Control and Prevention's Division of Healthcare Quality Promotion.

June 19th 2014

AJMC Sets Infectious Disease Meeting for Atlanta

The American Journal of Managed Care will host a two-day event September 25-26, 2014, to take on some of healthcare's biggest challenges: Treatments that cure hepatitis C are making news but upending balance sheets. A recent recommendation seeks preventive therapy to stop new cases of HIV. Hospitals and public health officials are grappling with how to prevent the spread of MERS. Only AJMC will bring payers, clinicians, policy leaders, and pharmaceutical representatives together to share ideas.

David Alain Wohl, MD, Discusses Strategies to Improve HIV Management

June 9th 2014

David Alain Wohl, MD, Discusses Strategies to Improve HIV Management

David Alain Wohl, MD, associate professor, division of infectious diseases, University of North Carolina at Chapel Hill, suggests that quality management of HIV has, for the most part, been self-regulated. He says that when it comes to HIV management, there is a lack of feedback or "quality improvement mechanisms" outside the managed care setting.

April 23rd 2014

Fauci, Leading AIDS Researchers Discuss Vaccine Prospects in AJMC's Latest 'Evidence-Based' Title

Evidence-Based Immunology and Infectious Disease, the fourth title in the news series from The American Journal of Managed Care, launches with an issue that features interviews with leading AIDS researchers, a discussion of the challenges of paying for breakthrough therapies for hepatitis C, and new information on causes and treatments for rheumatoid arthritis.

April 22nd 2014

Coinfection With HCV Worsens the Condition of HIV Patients Receiving Antiretrovirals

Surabhi Dangi-Garimella, PhD

April 22nd 2014

PBM Reports High Usage of HIV, HCV Drugs Among ACA Clients

Mary K. Caffrey

April 22nd 2014

Increasing Access to HIV Care May Help Improve Outcomes

Marj P. Zimmerman, BSPharm, MS Stanton R. Mehr

April 22nd 2014

Fauci: Advances in HIV Therapy Have Saved Lives, but Vaccine Still Needed

Tracey L. Regan

April 21st 2014

The Hunt for the 'Most Satisfying Solution': Fauci, Researchers Discuss Search For AIDS Vaccine

Tracey L. Regan

April 9th 2014

Early Drug Claims Suggest Exchange Plan Enrollees Are Sicker Than Average

Offering a first glimpse of the health care needs of Americans who bought coverage through federal and state marketplaces, an analysis of the first two months of claims data shows the new enrollees are more likely to use expensive specialty drugs to treat conditions like HIV/AIDS and hepatitis C than those with job-based insurance.

Segment 8 - Future of Innovation and Treatment Costs

February 18th 2014

Segment 8 - Future of Innovation and Treatment Costs

In the concluding segment, Dr Fendrick asks the panel to provide closing remarks about the future of treating hepatitis C (HCV). Dr Afdal says he believes this is a moment in time where a revolution is taking place.

September 30th 2013

Participating Faculty: Addressing Adherence Challenges Associated With Antiretroviral Therapy: Focus on Noninfectious Diarrhea

July 1st 2013

HIV/AIDS Patients Recommended Earlier Intervention

July 23rd 2012

Global AIDS Conference Rally Calls for Cheaper Medicines, More Funding

July 17th 2012

Deciding On Truvada: Who Should Take A HIV Prevention Pill?

July 5th 2012

Rapid H.I.V. Home Test Wins Federal Approval

May 11th 2012

FDA Panel Says Yes to HIV Prevention Pill

May 3rd 2012

More Than 100 Are Charged in Medicare Fraud Sweep

April 26th 2012

HIV/AIDS Activists Hoping Anxiously that Healthcare Law Survives Supreme Court Review

...

26 27 28 29 30 31 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions